These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 4105253
1. [Agranulocytosis caused by medication]. Tidsskr Nor Laegeforen; 1971 Jun 10; 91(16):1248-9. PubMed ID: 4105253 [No Abstract] [Full Text] [Related]
2. Phenylbutazone, oxyphenbutazone labeling revised. FDA Drug Bull; 1984 Dec 10; 14(3):23-4. PubMed ID: 6526172 [No Abstract] [Full Text] [Related]
3. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Inman WH. Br Med J; 1977 Jun 11; 1(6075):1500-5. PubMed ID: 871632 [Abstract] [Full Text] [Related]
6. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I. Chaplin S. Adverse Drug React Acute Poisoning Rev; 1986 Jun 11; 5(2):97-136. PubMed ID: 3529881 [No Abstract] [Full Text] [Related]
17. [A case of agranulocytosis in the course of methisol treatment]. Ujda J. Wiad Lek; 1968 Apr 15; 21(8):679-81. PubMed ID: 4174600 [No Abstract] [Full Text] [Related]
18. [Agranulocytosis induced by an antithyroid drug in a 14-year-old girl]. Zwaveling-Soonawala N, Veenhoven RH, Wolfs TF, Bokma JA. Ned Tijdschr Geneeskd; 2005 Jan 08; 149(2):89-92. PubMed ID: 15688841 [Abstract] [Full Text] [Related]
19. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine). Krook G. Contact Dermatitis; 1975 Dec 08; 1(6):385-6. PubMed ID: 139265 [No Abstract] [Full Text] [Related]